

Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|14|24|2415-2427
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.14, Iss.24, 2008-08, pp. : 2415-2427
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Cell-Penetrating Peptides: Mechanisms and Applications
Current Pharmaceutical Design, Vol. 11, Iss. 28, 2005-11 ,pp. :


In Vivo Delivery of Morpholino Oligos by Cell-Penetrating Peptides
Current Pharmaceutical Design, Vol. 19, Iss. 16, 2013-05 ,pp. :




By Lindgren M.M. Hallbrink M.M. Prochiantz A.A. Langel U.U.
Trends in Pharmacological Sciences, Vol. 21, Iss. 3, 2000-03 ,pp. :